Patients with dementia caused by AD also differ in serum melanotransferrin (p97) levels—melanotransferrin levels were elevated three to fourfold in AD compared to non-AD dementia and normal controls (Kwan Kim et al., 2001). This evidence concerns the gene MELTF and dementia.